Want to see IN:TATVA full AI Analyst Report?
Tatva Chintan Pharma Chem Limited (TATVA) Income Statement
Tatva Chintan Pharma Chem Limited Income Statement
Last quarter (Q2 2027), Tatva Chintan Pharma Chem Limited's total revenue was $2.17B, an increase of 75.94% from the same quarter last year. In Q2, Tatva Chintan Pharma Chem Limited's net income was $214.51M. See Tatva Chintan Pharma Chem Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 5.06B | $ 3.83B | $ 3.43B | $ 4.24B | $ 4.34B | |
| $ 1.82B | $ 619.74M | $ 1.60B | $ 1.91B | $ 2.32B | |
| $ 1.25B | $ 529.16M | $ 138.32M | $ 491.26M | $ 356.65M | |
| Depreciation and Amortization | $ 368.47M | $ 276.59M | $ 256.05M | $ 95.55M | $ 81.80M |
| $ 967.07M | $ -875.86M | $ 693.88M | $ 680.24M | $ 1.09B | |
| $ 563.11M | $ 90.58M | $ 1.46B | $ 1.42B | $ 1.96B | |
| $ 6.98M | $ -14.79M | $ -1.03B | $ -972.59M | $ -923.59M | |
| $ 570.09M | $ 75.79M | $ 435.68M | $ 445.65M | $ 1.04B | |
| $ 420.54M | $ 57.13M | $ 303.54M | $ 454.87M | $ 958.74M | |
| Per Share Metrics | |||||
| Basic EPS | $ 17.98 | $ 2.44 | $ 13.26 | $ 20.52 | $ 44.59 |
| Diluted EPS | $ 17.98 | $ 2.44 | $ 13.26 | $ 20.52 | $ 44.59 |
| Weighted Average Shares Outstanding | 23.39M | 23.41M | 22.89M | 22.17M | 21.50M |
| Weighted Average Shares Outstanding (Diluted) | 23.39M | 23.41M | 22.89M | 22.17M | 21.50M |
Currency in INR